Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the ...

Women who have rebound weight gain after stopping Wegovy or similar jabs end up gaining more weight during pregnancy, leading ...

FAT jabs could harm mum and baby if taken too close to pregnancy, a study suggests. Women who used the GLP-1 injections, such ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

The surge in usage of 'GLP-1'-style weight loss medications is seeing a "ripple effect" begin to unfold, impacting eating patterns in a number of ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

Novo’s drug mimics the gut hormone GLP-1 and has proven itself in a range of health problems linked to obesity, including ...

"While semaglutide did not demonstrate efficacy in slowing the progression of Alzheimer's disease, the extensive body of evidence supporting semaglutide continues to provide benefits for individuals ...

Eli Lilly became the first healthcare company to hit a $1 trillion valuation (briefly on Nov. 21) MONDAY, Nov. 24, 2025 ...